Post Operative PainNCT06725862
Caudal Block vs Retrolaminar Block on Analgesic Consumption in Undescended Testis Surgeries
A study testing Retrolaminar Block (RLB) and Caudal Block (CB) in people with Post Operative Pain, run by Kanuni Sultan Suleyman Training and Research Hospital at 2 sites in Turkey (Türkiye).
Trial summary
This study compares the postoperative analgesic effectiveness of Caudal Block (CB) and Retrolaminar Block (RLB) in pediatric patients undergoing undescended testis surgeries. Both techniques aim to manage pain effectively and reduce reliance on systemic analgesics, improving recovery and minimizing complications. Read more about this study
- Who is it for?
- Ages 1 year to 7 years, men only
- Conditions the study is for
- Post Operative Pain
- What is being tested?
- Retrolaminar Block (RLB) and Caudal Block (CB)
- Type of treatment
- Surgery or procedure
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 60 participants
- Where
- 2 sitesTurkey (Türkiye)
- Study dates
- 15 Dec 2024to 16 Dec 2025
- Phase
- Interventional
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 1 year to 7 years
- Men only
- No healthy volunteers
- Child
Who may be able to join
- Pediatric patients aged 1-7 years. ASA (American Society of Anesthesiologists) physical status I or II. Scheduled for unilateral undescended testis surgery. Parental/guardian consent provided for study participation.
Who cannot join
- Age under 1 year or over 7 years. Neurological deficits. Coagulopathy or bleeding disorders. History of allergy to local anesthetics. Signs of redness, infection, or other abnormalities at the injection site. Congenital spinal anomalies. Intellectual disability or psychiatric disorders. Hepatic or renal impairment. Refusal to participate in the study by parents or guardians.
Trial locations and contacts
2 sites in 1 country. Contact the study team or a site near you to ask about taking part.
Turkey (Türkiye)2 sites, 2 recruiting
- Recruiting
Health Science University İstanbul Kanuni Sultan Süleyman Education and Training Hospital
Istanbul, 34303
Engin ihsan Turan, 05382431114, enginihsan@hotmail.com
- Recruiting
Zincirlikuyu Medicana Hospital
Istanbul
Selçuk Alver, Ass.Prof.Dr, +905435424234, selcukalver@yahoo.com
About this study
Official title: Comparison of the Effects of Caudal Block and Retrolaminar Block on Analgesic Consumption in Postoperative Pain Management for Pediatric Undescended Testis Surgeries
This study compares the postoperative analgesic effectiveness of Caudal Block (CB) and Retrolaminar Block (RLB) in pediatric patients undergoing undescended testis surgeries. Both techniques aim to manage pain effectively and reduce reliance on systemic analgesics, improving recovery and minimizing complications.
The double-blind, randomized controlled trial will include 1-7-year-old ASA I-II patients at two hospitals. Patients with specific contraindications (e.g., spinal anomalies, allergies, or infections) will be excluded. Randomization divides participants into two groups (CB and RLB), with pain assessments performed using the FLACC pain scale by a blinded nurse.
Read more
Procedures:
CB: 0.125% bupivacaine (1 mL/kg, max 20 mL) injected into the sacral canal under ultrasound guidance.
RLB: 0.25% bupivacaine (0.1 mL/kg) injected into the retrolaminar space at the L4 level under ultrasound guidance.
Postoperative pain will be evaluated at various intervals (30 minutes to 24 hours). Intravenous paracetamol or tramadol will be administered based on pain scores.
The study aims to compare pain scores, time to first analgesic requirement, and postoperative complications, contributing valuable data on these two regional anesthesia techniques in pediatric surgery.
Read the detailed description
Pediatric lower abdominal surgeries, especially undescended testis surgeries, are procedures that can cause significant pain in the postoperative period. Effective pain management in such surgeries is crucial to accelerate recovery in children and reduce complications associated with analgesic medications. Among the most commonly used regional anesthesia techniques for pediatric lower abdominal surgeries is the caudal block, which has provided effective pain management for many years. However, in recent years, ultrasound-guided trunkal nerve blocks have gained popularity due to their targeted and prolonged analgesic effects. One such block, the retrolaminar block (RLB), is a relatively new technique applied around the spinal laminae with local anesthetics and has been increasingly utilized in pediatric surgeries.
While the caudal block is widely used in lower abdominal surgeries, ensuring proper distribution of the anesthetic agent and monitoring for potential side effects during the procedure is necessary. In contrast, the retrolaminar block, performed reliably under ultrasound guidance, is suggested to provide longer-lasting analgesia compared to the caudal block. The RLB allows for broader spread of the local anesthetic in the paraspinal region, potentially affecting both lower and upper areas. However, studies comparing the postoperative analgesic effects of RLB and caudal block in pediatric patients are quite limited in the literature.
This study aims to compare the postoperative analgesic effectiveness of caudal block and retrolaminar block in pediatric patients undergoing undescended testis surgeries. The study evaluates differences between these two regional anesthesia techniques in terms of postoperative pain scores, time to first analgesic requirement, and postoperative complications. The limited data available on these block methods in the literature highlight the potential scientific contribution of this study.
This double-blind, randomized controlled trial will be conducted at Prof. Dr. Cemil Taşçıoğlu City Hospital and Zincirlikuyu Medicana Hospitals. Following clinical ethics committee approval, the study will include pediatric patients aged 1 to 7 years who are classified as ASA I-II and scheduled for unilateral undescended testis surgeries.
Patients under 1 year or over 7 years, those with neurological deficits, bleeding disorders, a history of allergies to local anesthetics, signs of redness or infection at the injection site during physical examination, congenital spinal anomalies, mental retardation, psychiatric disorders, liver or kidney disease, and those who do not consent to participate will be excluded from the study.
Randomization and blinding Randomization will be performed using a computer-generated randomization table, dividing patients into two groups: Retrolaminar Block (RLB) and Caudal Block (CB). Pain evaluation will be conducted using the FLACC pain scale, assessed by a blinded nurse. The anesthesiologist will be blinded to data collection related to analgesic requirements and postoperative complications. Transparent sterile drapes will be applied to all injection sites to blind the anesthesiologist to postoperative outcomes.
General anesthesia procedure All patients will receive 0.5 mg/kg oral midazolam as premedication. Following standard monitoring in the operating room, general anesthesia will be induced with 2 mg/kg intravenous propofol and 0.5 μg/kg fentanyl. After loss of the eyelash reflex, a laryngeal mask airway suitable for the patient's age and weight will be inserted without using muscle relaxants, and the patient will be connected to the anesthesia machine. Anesthesia will be maintained with 2% sevoflurane in a 50% air-oxygen mixture. Demographic data (age, weight, duration of surgery) and complications will be recorded.
Regional anesthesia procedure Blocks will be performed in the left lateral decubitus position under ultrasound guidance by a single experienced operator after induction of general anesthesia and securing the airway. A 22-G insulated 50-mm sonographic needle will be used for all injections. Ultrasound guidance will be performed using a linear probe (6.5-18 MHz) in nerve imaging mode.
Caudal Block (CB) procedure The surgical area will be sterilized with povidone-iodine. The sacral hiatus will be visualized using the out-of-plane transverse imaging technique, and 0.125% bupivacaine at a dose of 1 mL/kg (maximum 20 mL) will be injected into the sacral canal.
Retrolaminar Block (RLB) procedure Patients will be positioned in the left lateral decubitus position. Using a paramedian sagittal approach at the L4 vertebral level, the transverse process of L4 will be located with the ultrasound probe. A needle will then be advanced into the retrolaminar space between the L4 lamina and paraspinal muscles, and 0.25% bupivacaine at a dose of 0.1 mL/kg will be injected.
Caudal block has long been used as a method of pain relief in pediatric anesthesia, significantly improving postoperative comfort, relieving pain, and reducing side effects such as nausea and vomiting. Similarly, retrolaminar block, which is among the routine practices in our hospital, enhances postoperative comfort by better controlling pain. This technique provides safe and effective analgesia by targeting nerves through injections into the lamina region of the spine while minimizing spread to surrounding tissues. The efficacy and reliability of retrolaminar block support its preference in postoperative pain management.
Postoperative follow-up and pain evaluation Pain will be assessed using the FLACC pain scale at 30 minutes, and at 1, 2, 4, 6, 12, and 24 hours. Patients with scores of 2-4 will receive intravenous paracetamol, and those with scores above 4 will be given intravenous tramadol. The timing and amount of analgesic use will be recorded.
- Conditions
- Post Operative Pain
- Being tested
- Retrolaminar Block (RLB), Caudal Block (CB)
- Medical subject headings
- Pain, Postoperative
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Retrolaminar Block (RLB)Procedure or surgery
This intervention involves administering 0.25% bupivacaine (0.1 mL/kg) into the retrolaminar space at the L4 vertebral level using a 22-G insulated needle under ultrasound guidance in pediatric patients after induction of general anesthesia.
Caudal Block (CB)Procedure or surgery
This intervention involves administering 0.125% bupivacaine (1 mL/kg, maximum 20 mL) into the sacral canal using a 22-G insulated needle under ultrasound guidance in pediatric patients after induction of general anesthesia.
| Study group | Role | What they receive |
|---|---|---|
| Retrolaminar block group | Experimental | Pediatric patients in this group will receive a retrolaminar block (RLB) using 0.25% bupivacaine (0.1 mL/kg) injected into the retrolaminar space at the L4 vertebral level under ultrasound guidance after general anesthesia induction. Receives: Procedure: Retrolaminar Block (RLB) |
| Caudal Block (CB) Group | Active comparator | Pediatric patients in this group will receive a caudal block (CB) using 0.125% bupivacaine (1 mL/kg, maximum 20 mL) injected into the sacral canal under ultrasound guidance after general anesthesia induction. Receives: Procedure: Caudal Block (CB) |
What is being measured
The primary outcome is the main question the study is designed to answer.
Postoperative Pain Scores
Assessment of postoperative pain scores using the FLACC scale (Face, Legs, Activity, Cry, Consolability) at predefined intervals (30 minutes, 1, 2, 4, 6, 12, and 24 hours postoperatively). Scores range from 0 to 10, with higher scores indicating greater pain intensity.
Measured: Up to 24 hours postoperatively.
Secondary outcomes (3)
Time to First Analgesic Requirement
The time elapsed from the completion of the surgical procedure to the first administration of rescue analgesia (IV paracetamol or tramadol) based on FLACC scores.
Measured: Up to 24 hours postoperatively.
Total Analgesic Consumption
The cumulative amount of analgesic medications (paracetamol and/or tramadol) administered within the first 24 hours postoperatively.
Measured: Up to 24 hours postoperatively.
Incidence of Postoperative Complications
The occurrence of complications such as nausea, vomiting, or urinary retention associated with the analgesic techniques used.
Measured: Up to 24 hours postoperatively.
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted10 Dec 2024
- Study start15 Dec 2024
- Primary completion15 Dec 2025 (estimated)
- Study completion16 Dec 2025 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (1)Papers the sponsor has linked to this study.
- Other trials for Post Operative PainStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Other
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Triple blind
- Who is masked
- Participant, Investigator, Outcomes assessor
- Enrolment
- 60 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Kanuni Sultan Suleyman Training and Research Hospital
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Engin Ihsan Turan, Kanuni Sultan Suleyman Training and Research Hospital
- Investigators
- Engin ihsan Turan, Principal investigator, Health Science University İstanbul Kanuni Sultan Süleyman Education and Training Hospital
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT06725862
- Sponsor's protocol ID
- caudal vs retrolaminar
- Status last verified
- Feb 2025
- First submitted
- 5 Dec 2024
- Last updated
- 18 Feb 2025
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- Undecided
Publications
Ozen V, Umutoglu T, Turan EI, Ayas TA, Yigit D, Ciftci B, Alver S. Comparison of caudal and retrolaminar blocks for postoperative analgesia in pediatric orchidopexy: a randomized controlled trial. Minerva Anestesiol. 2026 Jun;92(6):560-568. doi: 10.23736/S0375-9393.25.19579-5. Epub 2026 Mar 26.
PubMed 41884978
Study at a glance
From the registry record, last updated by the sponsor on 18 Feb 2025. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Comparison of the Effects of Caudal Block and Retrolaminar Block on Analgesic Consumption in Postoperative Pain Management for Pediatric Undescended Testis Surgeries
- ClinicalTrials.gov ID
- NCT06725862
- Acronym / sponsor ID
- caudal vs retrolaminar
- Conditions
- Post Operative Pain
- Study type
- Interventional
- Recruitment status
- Recruiting
- Enrolment
- 60 participants (estimated)
- Lead sponsor
- Kanuni Sultan Suleyman Training and Research HospitalUniversity, hospital or other
- Study start
- 15 Dec 2024 (actual)
- Primary completion
- 15 Dec 2025 (estimated)
- Study completion
- 16 Dec 2025 (estimated)
- First posted
- 10 Dec 2024 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
This study compares the postoperative analgesic effectiveness of Caudal Block (CB) and Retrolaminar Block (RLB) in pediatric patients undergoing undescended testis surgeries. Both techniques aim to manage pain effectively and reduce reliance on systemic analgesics, improving recovery and minimizing complications.
The double-blind, randomized controlled trial will include 1-7-year-old ASA I-II patients at two hospitals. Patients with specific contraindications (e.g., spinal anomalies, allergies, or infections) will be excluded. Randomization divides participants into two groups (CB and RLB), with pain assessments performed using the FLACC pain scale by a blinded nurse.
Procedures:
CB: 0.125% bupivacaine (1 mL/kg, max 20 mL) injected into the sacral canal under ultrasound guidance.
RLB: 0.25% bupivacaine (0.1 mL/kg) injected into the retrolaminar space at the L4 level under ultrasound guidance.
Postoperative pain will be evaluated at various intervals (30 minutes to 24 hours). Intravenous paracetamol or tramadol will be administered based on pain scores.
The study aims to compare pain scores, time to first analgesic requirement, and postoperative complications, contributing valuable data on these two regional anesthesia techniques in pediatric surgery.
Detailed description
Pediatric lower abdominal surgeries, especially undescended testis surgeries, are procedures that can cause significant pain in the postoperative period. Effective pain management in such surgeries is crucial to accelerate recovery in children and reduce complications associated with analgesic medications. Among the most commonly used regional anesthesia techniques for pediatric lower abdominal surgeries is the caudal block, which has provided effective pain management for many years. However, in recent years, ultrasound-guided trunkal nerve blocks have gained popularity due to their targeted and prolonged analgesic effects. One such block, the retrolaminar block (RLB), is a relatively new technique applied around the spinal laminae with local anesthetics and has been increasingly utilized in pediatric surgeries.
While the caudal block is widely used in lower abdominal surgeries, ensuring proper distribution of the anesthetic agent and monitoring for potential side effects during the procedure is necessary. In contrast, the retrolaminar block, performed reliably under ultrasound guidance, is suggested to provide longer-lasting analgesia compared to the caudal block. The RLB allows for broader spread of the local anesthetic in the paraspinal region, potentially affecting both lower and upper areas. However, studies comparing the postoperative analgesic effects of RLB and caudal block in pediatric patients are quite limited in the literature.
This study aims to compare the postoperative analgesic effectiveness of caudal block and retrolaminar block in pediatric patients undergoing undescended testis surgeries. The study evaluates differences between these two regional anesthesia techniques in terms of postoperative pain scores, time to first analgesic requirement, and postoperative complications. The limited data available on these block methods in the literature highlight the potential scientific contribution of this study.
This double-blind, randomized controlled trial will be conducted at Prof. Dr. Cemil Taşçıoğlu City Hospital and Zincirlikuyu Medicana Hospitals. Following clinical ethics committee approval, the study will include pediatric patients aged 1 to 7 years who are classified as ASA I-II and scheduled for unilateral undescended testis surgeries.
Patients under 1 year or over 7 years, those with neurological deficits, bleeding disorders, a history of allergies to local anesthetics, signs of redness or infection at the injection site during physical examination, congenital spinal anomalies, mental retardation, psychiatric disorders, liver or kidney disease, and those who do not consent to participate will be excluded from the study.
Randomization and blinding Randomization will be performed using a computer-generated randomization table, dividing patients into two groups: Retrolaminar Block (RLB) and Caudal Block (CB). Pain evaluation will be conducted using the FLACC pain scale, assessed by a blinded nurse. The anesthesiologist will be blinded to data collection related to analgesic requirements and postoperative complications. Transparent sterile drapes will be applied to all injection sites to blind the anesthesiologist to postoperative outcomes.
General anesthesia procedure All patients will receive 0.5 mg/kg oral midazolam as premedication. Following standard monitoring in the operating room, general anesthesia will be induced with 2 mg/kg intravenous propofol and 0.5 μg/kg fentanyl. After loss of the eyelash reflex, a laryngeal mask airway suitable for the patient's age and weight will be inserted without using muscle relaxants, and the patient will be connected to the anesthesia machine. Anesthesia will be maintained with 2% sevoflurane in a 50% air-oxygen mixture. Demographic data (age, weight, duration of surgery) and complications will be recorded.
Regional anesthesia procedure Blocks will be performed in the left lateral decubitus position under ultrasound guidance by a single experienced operator after induction of general anesthesia and securing the airway. A 22-G insulated 50-mm sonographic needle will be used for all injections. Ultrasound guidance will be performed using a linear probe (6.5-18 MHz) in nerve imaging mode.
Caudal Block (CB) procedure The surgical area will be sterilized with povidone-iodine. The sacral hiatus will be visualized using the out-of-plane transverse imaging technique, and 0.125% bupivacaine at a dose of 1 mL/kg (maximum 20 mL) will be injected into the sacral canal.
Retrolaminar Block (RLB) procedure Patients will be positioned in the left lateral decubitus position. Using a paramedian sagittal approach at the L4 vertebral level, the transverse process of L4 will be located with the ultrasound probe. A needle will then be advanced into the retrolaminar space between the L4 lamina and paraspinal muscles, and 0.25% bupivacaine at a dose of 0.1 mL/kg will be injected.
Caudal block has long been used as a method of pain relief in pediatric anesthesia, significantly improving postoperative comfort, relieving pain, and reducing side effects such as nausea and vomiting. Similarly, retrolaminar block, which is among the routine practices in our hospital, enhances postoperative comfort by better controlling pain. This technique provides safe and effective analgesia by targeting nerves through injections into the lamina region of the spine while minimizing spread to surrounding tissues. The efficacy and reliability of retrolaminar block support its preference in postoperative pain management.
Postoperative follow-up and pain evaluation Pain will be assessed using the FLACC pain scale at 30 minutes, and at 1, 2, 4, 6, 12, and 24 hours. Patients with scores of 2-4 will receive intravenous paracetamol, and those with scores above 4 will be given intravenous tramadol. The timing and amount of analgesic use will be recorded.
Study design
- Primary purpose
- Other
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Triple blind (participant, investigator, outcomes assessor)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| Retrolaminar block group | Experimental | Procedure: Retrolaminar Block (RLB)Pediatric patients in this group will receive a retrolaminar block (RLB) using 0.25% bupivacaine (0.1 mL/kg) injected into the retrolaminar space at the L4 vertebral level under ultrasound guidance after general anesthesia induction. |
| Caudal Block (CB) Group | Active comparator | Procedure: Caudal Block (CB)Pediatric patients in this group will receive a caudal block (CB) using 0.125% bupivacaine (1 mL/kg, maximum 20 mL) injected into the sacral canal under ultrasound guidance after general anesthesia induction. |
Who may qualify
- Ages
- 1 year to 7 years
- Sex
- Male only
- Healthy volunteers
- Not accepted
- Age groups
- Child
Key inclusion criteria (1 listed)
- Pediatric patients aged 1-7 years. ASA (American Society of Anesthesiologists) physical status I or II. Scheduled for unilateral undescended testis surgery. Parental/guardian consent provided for study participation.
Key exclusion criteria (1 listed)
- Age under 1 year or over 7 years. Neurological deficits. Coagulopathy or bleeding disorders. History of allergy to local anesthetics. Signs of redness, infection, or other abnormalities at the injection site. Congenital spinal anomalies. Intellectual disability or psychiatric disorders. Hepatic or renal impairment. Refusal to participate in the study by parents or guardians.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Retrolaminar Block (RLB)This intervention involves administering 0.25% bupivacaine (0.1 mL/kg) into the retrolaminar space at the L4 vertebral level using a 22-G insulated needle under ultrasound guidance in pediatric patients after induction of general anesthesia. | Procedure or surgery | Retrolaminar block group |
| Caudal Block (CB)This intervention involves administering 0.125% bupivacaine (1 mL/kg, maximum 20 mL) into the sacral canal using a 22-G insulated needle under ultrasound guidance in pediatric patients after induction of general anesthesia. | Procedure or surgery | Caudal Block (CB) Group |
Primary outcome
Postoperative Pain Scores
Time frame: Up to 24 hours postoperatively.
Assessment of postoperative pain scores using the FLACC scale (Face, Legs, Activity, Cry, Consolability) at predefined intervals (30 minutes, 1, 2, 4, 6, 12, and 24 hours postoperatively). Scores range from 0 to 10, with higher scores indicating greater pain intensity.
3 secondary outcomes
Time to First Analgesic Requirement
Time frame: Up to 24 hours postoperatively.
Total Analgesic Consumption
Time frame: Up to 24 hours postoperatively.
Incidence of Postoperative Complications
Time frame: Up to 24 hours postoperatively.
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 18 Feb 2025.
- Derived from this study: PubMed 41884978Ozen V, Umutoglu T, Turan EI, Ayas TA, Yigit D, Ciftci B, Alver S. Comparison of caudal and retrolaminar blocks for postoperative analgesia in pediatric orchidopexy: a randomized controlled trial. Minerva Anestesiol. 2026 Jun;92(6):560-568. doi: 10.23736/S0375-9393.25.19579-5. Epub 2026 Mar 26.
- Individual participant dataSharing planned: Undecided
Related trials for Post Operative Pain
RecruitingPhase 4
ESP Blocks for Posterior Spinal Fusion
Postoperative Pain
Recruiting
Effect of Cryotherapeutic and Nanotherapeutic Sodium Hypochlorite on Post-Operative Endodontic Pain.
Symptomatic Irreversible Pulpitis, Symptomatic Apical Periodontitis
RecruitingPhase 2
REctus Sheath Trial
Acute Pain, Postoperative Pain, Acute
Not yet recruiting
Effect of Pectoral Nerve Block (PECS) Using Magnesium Sulfate Added to Dexamethasone on Quality of Recovery and Chronic Post-Mastectomy Pain
Breast Cancer, Postoperative Pain
Active, not recruitingPhase 4
Effect of Dexmedetomidine on Postoperative Pain in Spinal Anesthesia for Cesarean Section at Assuit University Hospital
Cesarean Section
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
Engin ihsan Turan principal investigator
Health Science University İstanbul Kanuni Sultan Süleyman Education and Training Hospital
2 sites in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Retrolaminar Block (RLB) and Caudal Block (CB) in people with Post Operative Pain, run by Kanuni Sultan Suleyman Training and Research Hospital at 2 sites in Turkey (Türkiye).
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: looking for participants now, as of the sponsor's last update on 18 Feb 2025. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 2 sites in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact Engin ihsan Turan (05382431114, enginihsan@hotmail.com), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Postoperative Pain Scores (time frame: Up to 24 hours postoperatively.). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT06725862, which also lists 1 linked publication.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 18 Feb 2025; AzTrials last refreshed its copy on 7 Nov 2026.